Root Financial Partners’s Rapport Therapeutics RAPP Stock Holding History

Root Financial Partners’s Portfolio RAPP Stock Details RAPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$34	Buy	+1	New	+$43	﹤0.01%	3757

Other funds holding RAPP

Catalyst Private Wealth San Mateo, California $239M AUM 21.76% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Root Financial Partners's RAPP Position: Q3 2026 in Review

Root Financial Partners opened a new position in Rapport Therapeutics (RAPP) in Q3 2026: 1 share worth $34. The stake represents ﹤0.01% of the portfolio and ranks #3757 among its holdings.

13 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

Root Financial Partners held 1 share of Rapport Therapeutics worth $34 as of Q3 2026.
Rapport Therapeutics was a new Root Financial Partners position in Q3 2026.
Rapport Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3757 holding.
13 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.